Study S000554

Randomized Clinical Trial to Evaluate the Use of Liraglutide in Individuals With Brain Death and Anti-inflammatory and Anti-apoptotic Effects on Organs to be Transplanted

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03672812
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: DOUBLE
Status: COMPLETED
Enrollment: 50
Start: 2018-09-01
Primary completion: 2019-12-10
Lead sponsor: Hospital de Clinicas de Porto Alegre
Conditions: Brain Death
Interventions: DRUG:Liraglutide
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

change inflammation [from 6 hours to 24 hours]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.